Researchers track Real-World data to find best next steps for liver cancer patients

NCT ID NCT06117891

Recruiting now Knowledge-focused Sponsor: Bayer Source: ClinicalTrials.gov ↗

Summary

This study aims to understand which treatments work best for advanced liver cancer patients after they've received initial immunotherapy combinations. Researchers will collect data from 300 adults who have already started their next treatment as part of their regular care. By tracking survival, treatment duration, and tumor response, the study seeks to determine the optimal sequence of therapies for better patient outcomes.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Corporal Michael J Crescenz Department Of Veterans Affairs Medical Center
NOT_YET_RECRUITING

Philadelphia, Pennsylvania, 19104, United States
Einstein Medical Center
NOT_YET_RECRUITING

Philadelphia, Pennsylvania, 19141, United States
Many Locations
RECRUITING

Multiple Locations, Argentina
Many Locations
ACTIVE_NOT_RECRUITING

Multiple Locations, Brazil
Many Locations
RECRUITING

Multiple Locations, China
Many Locations
RECRUITING

Multiple Locations, Colombia
Many Locations
ACTIVE_NOT_RECRUITING

Multiple Locations, France
Many Locations
ACTIVE_NOT_RECRUITING

Multiple Locations, Greece
Many Locations
ACTIVE_NOT_RECRUITING

Multiple Locations, Italy
Many Locations
WITHDRAWN

Multiple Locations, Mexico
Many Locations
NOT_YET_RECRUITING

Multiple Locations, Saudi Arabia
Many Locations
ACTIVE_NOT_RECRUITING

Multiple Locations, South Korea
Many Locations
ACTIVE_NOT_RECRUITING

Multiple Locations, Spain
Many Locations
RECRUITING

Multiple Locations, Taiwan
Many Locations
ACTIVE_NOT_RECRUITING

Multiple Locations, Thailand
Many Locations
WITHDRAWN

Multiple Locations, Turkey (Türkiye)
Mercy Medical Center - Medline Healthcare Services LLC
NOT_YET_RECRUITING

Baltimore, Maryland, 21202, United States
Roswell Park Comprehensive Cancer Center
NOT_YET_RECRUITING

Buffalo, New York, 14203, United States
University Of Cincinnati Division Of Hematology Oncology - UC Health System
NOT_YET_RECRUITING

Cincinnati, Ohio, 45219, United States
University of Michigan Health System
NOT_YET_RECRUITING

Ann Arbor, Michigan, 48109, United States

Conditions

Explore the condition pages connected to this study.

UNRESECTABLE HEPATOCELLULAR CARCINOMA